TASTYLIA 5 contains Tadalafil 5 mg, a clinically proven and FDA-approved phosphodiesterase type 5 (PDE5) inhibitor used primarily in the treatment of erectile dysfunction (ED) and benign prostatic hyperplasia (BPH). This low-dose formulation is ideal for once-daily administration, providing a steady level of Tadalafil in the bloodstream for improved sexual spontaneity and urinary flow improvement in BPH patients.

Unlike higher doses used on-demand, TASTYLIA 5 is optimized for daily therapy, enabling men to experience continuous readiness without the need to time medication before sexual activity. It is also suitable for men who require both ED and BPH treatment concurrently.

TASTYLIA 5 is manufactured under WHO-GMP certified standards and is represented globally by BLUEPILL EXPRESS, a renowned third-party pharmaceutical manufacturer and exporter. This makes it an excellent choice for bulk export, contract manufacturing, or branded generic distribution under private labeling.

Contains Tadalafil 5 mg for low-dose daily therapy

Helps manage erectile dysfunction and BPH symptoms

Enables spontaneous intimacy without pre-planning

Provides 24-hour therapeutic coverage

Available in tablet or orally disintegrating strip (ODS) form

Manufactured under stringent global GMP standards

Represented by BLUEPILL EXPRESS, a global pharma exporter

Ideal for custom branding, private labeling, and B2B distribution